System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or modelbased controller coupled to a singleneedle or multi-needle intradermal (ID) delivery device
Details for Australian Patent Application No. 2003287073 (hide)
International Classifications
Event Publications
1 April 2004 Complete Application Filed
Priority application(s): 60/432,233 11.12.02 US; 60/417,559 11.10.02 US
16 June 2005 Amendment Made
The nature of the amendment is: Amend the name of the applicant from Becton Dickinson and Company to Becton, Dickinson and Company
16 June 2005 Section 223 Application Allowed
BECTON, DICKINSON AND COMPANY The time in which to enter the National Phase has been extended to 11 Jun 2005. Address for service in Australia - FB Rice & Co Level 23 44 Market Street SYDNEY NSW 2000
8 September 2005 Application Open to Public Inspection
Published as AU-B-2003287073
8 January 2009 Application Accepted
Published as AU-B-2003287073
7 May 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003287074-Halogenated selective androgen receptor modulators and methods of use thereof
2003287072-CHANNEL-REINFORCED LIGHTWEIGHT PRECAST CONCRETE WALL PANEL SYSTE M
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser